Moshe Alafi

Moshe Alafi discloses dealings in 3 companies, chiefly Intra-Cellular Therapies, Inc., Molecular Devices Corp and Stereotaxis, Inc. The record holds 17 filings, for trades running from 15 November 2006 to 2 October 2017.

In open-market terms, that means 13 purchases worth €5.6M on one side and 1 sale worth €73k on the other. Netting one side against the other leaves €5.5M of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 share grant. So far in 2017, the count stands at 1 purchase and no sales.

The median purchase comes to €63k. Clusters matter here: 4 out of 4 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The latest filing, published on 3 October 2017, reports an open-market purchase of €3.4M in Intra-Cellular Therapies, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.